Enara Bio

Enara Bio develops cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients with solid tumors.

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series A
Initial Investment Year
2020
Enara Bio Hover Image